home+bepo

Controlled release technology

Discover BEPO™, our proprietary, game-changing technology platform for the next generation of controlled and sustained drug delivery thanks to its flexibility and low manufacturing cost. BEPO™ physicochemical properties make it an ideal vehicle for a broad variety of Active Pharmaceutical Ingredients (APIs). read more
stones2

Best in class products

Burst control, flexible duration control, broad API compatibility, low manufacturing costs, compliance improvement, rapid formulation, reduced environmental impacts: BEPO™ technology offers a balanced approach and all benefits to create best in class products. read more
applications2+bepo

Applications

Because chronic pathologies and many human diseases require one or more daily treatments - in some cases for a period of several weeks, months or years, our BEPO™ technology represents a significant benefit in dosage profiles and patient care. read more

a game-changing drug delivery technology

Share the vision?

We innovate for Global Health

With existing pharmaceutical business models, global health markets have a challenge to address. In order to service this truly global market, MedinCell is dedicated to innovation to deliver revolutionary medical treatments technologies to the global community, regardless of local economic conditions. We are empowering our partners to develop the next generation of best in class medicines that incorporate potent ecological and compliance-related benefits.

Improving worldwide access to medicine is a goal that cannot be achieved without robust financial success and careful planning.  Free of external financial interests and focused on global health, we incorporate scientific and humanitarian goals into our business as long-term strategic objectives. As a hybrid organization, we work simultaneously on for-profit and non-profit activities.

MedinCell is a self-funded and employee-owned entity. Our success is due to the skills and commitment of our employees. To attract and retain the best talents in the biotechnological and pharmaceutical industry, we offer a proactive and creative environment where individuals can participate and contribute to the overall success of the company.  read more

We are MedinCell

TDE

Thibaut Deramoudt

NHE

Nicolas Heuzé

CGE

Camille Geissmann

RAL

Rachel Almeras

BJA

Benjamin Jacquot

VBS

Victoire Bancelin-Selinsky

AVA

Alicia Vallet

ABR

Aurélie Briault

LCH

Laura Champion

SFR

Simon Frydrych

JHU

Jacqueline Huet

ANG

Anh Nguyen

JWE

Johannes Wennink

NRI

Najim Richa

test

Peter Mitchell

JCO

Julien Courtès

OHA

Olivier Habeillon

MDE

Marielle Dedieu

MKR

Max Kroll

JDE

Jacques Descotes

MCA

Mélodie Carluer

CDU

Camille Dulac

NBA

Nadia Black

ABA

Anta Ba

SGR

Sylvestre Grizot

CPE

Charlotte Peloso

CRO

Christophe Roberge

ARE

Anthony Rech

GMA

Giuliana Martelli

FLL

Fang Liu-Lopez

ABU

Anne Baud

JMC

Jean-Manuel Cros

FHO

Florian Hocine

ALG

Anne-Lise Glotin

ACH

Amélie Chevalier

ALO

Adolfo Lopez Noriega

CBR

Clémence Bryon

NHE

Natasha Hewitt

MAB

Myriam Abbassy

DMO

Domingos Monteiro

ABU

Andrius Bubliauskas

2

Lorenzo Ramos

ALC

Anne-Laure Courjaud

SEN

Sébastien Enault

MSI

Marie Simon

ALB

Anne-Laure Barbe

MFE

Maria Ferrand

MJU

Melanie Julien